Your browser doesn't support javascript.
loading
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.
Kottschade, Lisa A; Pond, Gregory Russell; Olszanski, Anthony J; Zakharia, Yousef; Domingo-Musibay, Evidio; Hauke, Ralph J; Curti, Brendan D; Schober, Sarah; Milhem, Mohammed M; Block, Matthew Stephen; Hieken, Tina; McWilliams, Robert R.
Afiliación
  • Kottschade LA; Mayo Clinic, Rochester, Minnesota.
  • Pond GR; Ontario Clinical Oncology Group, McMaster University, Hamilton, Ontario.
  • Olszanski AJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Zakharia Y; University of Iowa, Iowa City, Iowa.
  • Domingo-Musibay E; University of Minnesota, Minneapolis, Minnesota.
  • Hauke RJ; Nebraska Cancer Specialists-Midwest Cancer Center, Omaha, Nebraska.
  • Curti BD; Portland Providence Medical Center, Portland, Oregon.
  • Schober S; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Milhem MM; University of Iowa, Iowa City, Iowa.
  • Block MS; Mayo Clinic, Rochester, Minnesota.
  • Hieken T; Mayo Clinic, Rochester, Minnesota.
  • McWilliams RR; Mayo Clinic, Rochester, Minnesota.
Clin Cancer Res ; 29(12): 2220-2225, 2023 06 13.
Article en En | MEDLINE | ID: mdl-37000165
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Melanoma Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Melanoma Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article